This is how India is disposing of its lakhs & lakhs of Covid vaccine syringes
Each syringe is as light as a one-rupee coin, so experts say the management of waste from the vaccination drive is not difficult to tackle.
Himani Chandna 10 April, 2021 10:06 am IST
A+
New Delhi: First there were the PPE kits, with masks, gowns, face shields, gloves, etc, being used by healthcare and frontline workers, and diagnostic equipment for conducting Covid-19 tests. Now, there are syringes lakhs and lakhs of them for India’s Covid vaccination drive, which is the world’s largest.
Since it took hold last year, the Covid pandemic has resulted in the generation of tonnes of biomedical waste.
High costs of 24 medical devices trigger suspicion; govt seeks price details
While the prices of four categories of medical devices - coronary stents, drug-eluting stents, condoms, and intrauterine devices - are already fixed by NPPA, the prices of the rest are fixed by the manufacturers themselves
Joe C Mathew | February 22, 2021 | Updated 12:39 IST
All medical devices are now regulated under Drugs Act though only 37 have so far been notified for compliance
India s medicine price regulator National Pharmaceutical Pricing Authority (NPPA) has given three weeks time to manufacturers and importers of 24 categories of medical devices to furnish pricing details of all such products.
Industry calls Union Budget 2021-22 ambitious but awaits implementation
Industry calls Union Budget 2021-22 ambitious but awaits implementation
01 February 2021 | News
Image Credit: shutterstock.com
Soon after the Union Budget 2021-22 was presented by the Finance Minister Nirmala Sitharaman where she strongly positioned Health & Wellbeing as one of the 6 crucial pillars of Aatma Nirbhar Bharat, industry s responses started pouring in.
BioSpectrum brings to you the post-budget reactions of the pharma & healthcare industry-
I am happy to see the investment in healthcare increase to such a level because it has been long overdue.
Kiran Mazumdar Shaw, Executive Chairperson, Biocon, Bengaluru
Setting up of rural and urban health and wellness centres could be an opportunity to create a PPP model. The partnership-driven approach is a sure step for the entities to bring to these hospitals their inherent areas of strength, thus building a quality model of care. Thi
An industry body has accused the Centre of abruptly increasing the accuracy thresholds for rapid antigen tests used to detect the novel coronavirus, effectively granting a South Korean company a monopoly and eliminating Indian companies from government orders.
The Association of Indian Medical Device Industry (AIMED) has questioned the Centre’s decision to “all of a sudden” change the required accuracy thresholds a sensitivity of 84 per cent from 50 per cent and a specificity of 100 per cent from 95 per cent.
Sensitivity measures true positives while specificity measures true negatives in the tested samples. A sensitivity of 84 per cent and specificity of 100 per cent would mean the test should yield no more than 16 per cent false positives and zero per cent false negatives.